Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDay one on Mounjaro is quieter than most people expect. The first dose is 2.5 mg — a dose chosen entirely to let your body adjust, not to drive immediate weight loss — and many people feel little beyond mild nausea, if that. Mounjaro is a prescription-only medicine: a GPhC-registered Independent Prescriber must assess your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before you open the box, a few practical things matter. The pen lives in the fridge at 2–8 °C; take it out roughly 30 minutes before you plan to inject and let it reach room temperature, cold liquid is harder on the injection site. Pick a site (abdomen, outer thigh or upper arm all work), clean the skin, and follow the steps in the Patient Information Leaflet exactly. The leaflet is the clinical document your prescriber works from; it supersedes anything you read online, including this page.
If it's your first injection ever, that's worth acknowledging, needles are nerve-wracking for plenty of people. The KwikPen is designed to make it straightforward, with an automatic needle cover that activates after use. Still, if technique is something you want to talk through, our support team is available seven days a week.
Inject at a consistent day each week. Whether you do it in the morning or evening matters less than keeping the gap to roughly 7 days. You can find more on the logistics of early treatment on our detailed day-one guide.
Tirzepatide activates two gut-hormone receptors simultaneously) GIP and GLP-1, which slow gastric emptying and signal fullness. On day one, that process starts within hours of the injection. For most people, the most noticeable early effect is simply feeling fuller sooner at a meal, or finding that the urge to snack fades a little. Some people feel nothing unusual at all during the first 24 hours.
Nausea is the most commonly reported side effect across the NHS medicines guidance for tirzepatide and the clinical trial data. At 2.5 mg it tends to be mild, and for many people it settles within a day or two. If eating a smaller, lower-fat meal around injection time helps (many patients find it does) that's a practical adjustment, not a rule. Diarrhoea, constipation and indigestion are also possible; they're part of the same gastric-slowing picture. What you should not do is change your dose or timing without speaking to your prescriber. For a closer look at how the second and third days tend to differ from the first, the day-two breakdown and day-three guide cover the patterns most patients report.
Nothing is off the menu on day one in a clinical sense, but smaller portions of lower-fat food sit more comfortably while gastric emptying is slower. Staying hydrated matters more than it might sound: if nausea or vomiting does occur, even mild dehydration can compound it. Alcohol isn't forbidden by the medicine, but it can worsen nausea and adds calorie-dense liquid your appetite signals are already trying to reduce, most people find less of it works better.
Protein is worth prioritising from the start. Appetite suppression is a feature, not a problem, but eating too little protein while losing weight risks muscle alongside fat. This is background context, not a prescription; a dietitian or your prescriber can turn it into a plan that fits your situation. The broader picture of what treatment looks like (and what it costs as a private patient) is covered on our Mounjaro cost page if that's useful background.
Most day-one experiences are uneventful. A small number of people do have symptoms that need prompt attention. Severe or persistent stomach pain that radiates to the back (with or without vomiting) is a symptom of pancreatitis, which the MHRA identified as an infrequent but potentially serious risk in a Drug Safety Update issued in January 2026; get medical help the same day if that describes what you feel. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing) are a 999 situation.
Everyday nausea or loose stools are not emergencies. Rest, hydration and a smaller next meal usually help. If you're unsure whether a symptom is normal, our prescribers are reachable seven days a week, that aftercare is part of the service, not an add-on. You can also report any suspected side effects directly to the MHRA via the Yellow Card scheme. For context on what days three to five typically look like as the medicine settles, see the day-five guide and the day-four overview. And if you're still weighing up whether Mounjaro is the right option, our free consultation is the right starting point, a real prescriber reviews every assessment the same day it's submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.